Genticel Company
.jpg)
Gentiel develops therapeutic vaccines for the prevention of cervical cancer in HPV infected women.
Founded Date:
2001-01-01
Total Funding:
$41 382 652
Funding Status:
M&A
Last Funding Type:
Series D
Last Funding Date:
2013-04-24
Industry:
Longevity
Headquarters:
Paris, Ile-de-France, France